APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oncology (Anti-cancer Drugs)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Oncology (Anti-cancer Drugs) Market Analysis and Forecast 2026-2032

21 December 2025198 pages

Choose your research edition.

Industry ResearchOncology (Anti-cancer Drugs) Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Oncology (Anti-cancer Drugs) Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Oncology (Anti-cancer Drugs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oncology (Anti-cancer Drugs) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Oncology (Anti-cancer Drugs) Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Oncology (Anti-cancer Drugs) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Oncology (Anti-cancer Drugs) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Oncology (Anti-cancer Drugs) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Oncology (Anti-cancer Drugs) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Oncology (Anti-cancer Drugs) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Oncology (Anti-cancer Drugs) include Sanofi, Johnson & Johnson, Novartis, Merck, Roche, Eli lilly, Pfizer, GlaxoSmithKline and Amgen, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Oncology (Anti-cancer Drugs), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Oncology (Anti-cancer Drugs), also provides the sales of main regions and countries. Of the upcoming market potential for Oncology (Anti-cancer Drugs), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oncology (Anti-cancer Drugs) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oncology (Anti-cancer Drugs) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Oncology (Anti-cancer Drugs) sales, projected growth trends, production technology, application and end-user industry.

Oncology (Anti-cancer Drugs) Segment by Company

Sanofi

Johnson & Johnson

Novartis

Merck

Roche

Eli lilly

Pfizer

GlaxoSmithKline

Amgen

Celgene

Oncology (Anti-cancer Drugs) Segment by Type

Blood Cancer

Gastrointestinal Cancer

Breast Cancer

Prostate Cancer

Others

Oncology (Anti-cancer Drugs) Segment by Application

Immunotherapy (Biologic Therapy)

Hormonal Therapy

Chemotherapy

Targeted Therapy

Others

Oncology (Anti-cancer Drugs) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncology (Anti-cancer Drugs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oncology (Anti-cancer Drugs) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncology (Anti-cancer Drugs).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Oncology (Anti-cancer Drugs) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Oncology (Anti-cancer Drugs) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oncology (Anti-cancer Drugs) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oncology (Anti-cancer Drugs) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Blood Cancer Major Manufacturers Table 3. Gastrointestinal Cancer Major Manufacturers Table 4. Breast Cancer Major Manufacturers Table 5. Prostate Cancer Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Oncology (Anti-cancer Drugs) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Immunotherapy (Biologic Therapy) Major Manufacturers Table 9. Hormonal Therapy Major Manufacturers Table 10. Chemotherapy Major Manufacturers Table 11. Targeted Therapy Major Manufacturers Table 12. Others Major Manufacturers Table 13. Oncology (Anti-cancer Drugs) Industry Trends Table 14. Oncology (Anti-cancer Drugs) Industry Drivers Table 15. Oncology (Anti-cancer Drugs) Industry Opportunities and Challenges Table 16. Oncology (Anti-cancer Drugs) Industry Restraints Table 17. Global Oncology (Anti-cancer Drugs) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Oncology (Anti-cancer Drugs) Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Oncology (Anti-cancer Drugs) Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Region (2021-2026) Table 21. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Region (2027-2032) Table 22. Global Oncology (Anti-cancer Drugs) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k tons) Table 23. Global Oncology (Anti-cancer Drugs) Sales by Region (2021-2026) & (k tons) Table 24. Global Oncology (Anti-cancer Drugs) Sales by Region (2027-2032) & (k tons) Table 25. Global Oncology (Anti-cancer Drugs) Sales Market Share by Region (2021-2026) Table 26. Global Oncology (Anti-cancer Drugs) Sales Market Share by Region (2027-2032) Table 27. Global Oncology (Anti-cancer Drugs) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Oncology (Anti-cancer Drugs) Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Oncology (Anti-cancer Drugs) Sales Market Share by Manufacturers (2021-2026) Table 31. Global Oncology (Anti-cancer Drugs) Sales Price (US$/ton) of Manufacturers (2021-2026) Table 32. Global Oncology (Anti-cancer Drugs) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Oncology (Anti-cancer Drugs) Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Oncology (Anti-cancer Drugs) Manufacturers, Product Type & Application Table 35. Global Oncology (Anti-cancer Drugs) Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Oncology (Anti-cancer Drugs) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Oncology (Anti-cancer Drugs) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Oncology (Anti-cancer Drugs) Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Oncology (Anti-cancer Drugs) Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Type (2021-2026) Table 42. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Type (2027-2032) Table 43. Global Oncology (Anti-cancer Drugs) Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 44. Global Oncology (Anti-cancer Drugs) Sales by Type (2021-2026) & (k tons) Table 45. Global Oncology (Anti-cancer Drugs) Sales by Type (2027-2032) & (k tons) Table 46. Global Oncology (Anti-cancer Drugs) Sales Market Share by Type (2021-2026) Table 47. Global Oncology (Anti-cancer Drugs) Sales Market Share by Type (2027-2032) Table 48. Global Oncology (Anti-cancer Drugs) Price by Type (2021-2026) & (US$/ton) Table 49. Global Oncology (Anti-cancer Drugs) Price by Type (2027-2032) & (US$/ton) Table 50. Global Oncology (Anti-cancer Drugs) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Oncology (Anti-cancer Drugs) Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Oncology (Anti-cancer Drugs) Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Application (2021-2026) Table 54. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Application (2027-2032) Table 55. Global Oncology (Anti-cancer Drugs) Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 56. Global Oncology (Anti-cancer Drugs) Sales by Application (2021-2026) & (k tons) Table 57. Global Oncology (Anti-cancer Drugs) Sales by Application (2027-2032) & (k tons) Table 58. Global Oncology (Anti-cancer Drugs) Sales Market Share by Application (2021-2026) Table 59. Global Oncology (Anti-cancer Drugs) Sales Market Share by Application (2027-2032) Table 60. Global Oncology (Anti-cancer Drugs) Price by Application (2021-2026) & (US$/ton) Table 61. Global Oncology (Anti-cancer Drugs) Price by Application (2027-2032) & (US$/ton) Table 62. Sanofi Company Information Table 63. Sanofi Business Overview Table 64. Sanofi Oncology (Anti-cancer Drugs) Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 65. Sanofi Oncology (Anti-cancer Drugs) Product Portfolio Table 66. Sanofi Recent Development Table 67. Johnson & Johnson Company Information Table 68. Johnson & Johnson Business Overview Table 69. Johnson & Johnson Oncology (Anti-cancer Drugs) Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 70. Johnson & Johnson Oncology (Anti-cancer Drugs) Product Portfolio Table 71. Johnson & Johnson Recent Development Table 72. Novartis Company Information Table 73. Novartis Business Overview Table 74. Novartis Oncology (Anti-cancer Drugs) Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 75. Novartis Oncology (Anti-cancer Drugs) Product Portfolio Table 76. Novartis Recent Development Table 77. Merck Company Information Table 78. Merck Business Overview Table 79. Merck Oncology (Anti-cancer Drugs) Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 80. Merck Oncology (Anti-cancer Drugs) Product Portfolio Table 81. Merck Recent Development Table 82. Roche Company Information Table 83. Roche Business Overview Table 84. Roche Oncology (Anti-cancer Drugs) Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 85. Roche Oncology (Anti-cancer Drugs) Product Portfolio Table 86. Roche Recent Development Table 87. Eli lilly Company Information Table 88. Eli lilly Business Overview Table 89. Eli lilly Oncology (Anti-cancer Drugs) Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 90. Eli lilly Oncology (Anti-cancer Drugs) Product Portfolio Table 91. Eli lilly Recent Development Table 92. Pfizer Company Information Table 93. Pfizer Business Overview Table 94. Pfizer Oncology (Anti-cancer Drugs) Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 95. Pfizer Oncology (Anti-cancer Drugs) Product Portfolio Table 96. Pfizer Recent Development Table 97. GlaxoSmithKline Company Information Table 98. GlaxoSmithKline Business Overview Table 99. GlaxoSmithKline Oncology (Anti-cancer Drugs) Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 100. GlaxoSmithKline Oncology (Anti-cancer Drugs) Product Portfolio Table 101. GlaxoSmithKline Recent Development Table 102. Amgen Company Information Table 103. Amgen Business Overview Table 104. Amgen Oncology (Anti-cancer Drugs) Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 105. Amgen Oncology (Anti-cancer Drugs) Product Portfolio Table 106. Amgen Recent Development Table 107. Celgene Company Information Table 108. Celgene Business Overview Table 109. Celgene Oncology (Anti-cancer Drugs) Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 110. Celgene Oncology (Anti-cancer Drugs) Product Portfolio Table 111. Celgene Recent Development Table 112. North America Oncology (Anti-cancer Drugs) Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Oncology (Anti-cancer Drugs) Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Oncology (Anti-cancer Drugs) Sales by Type (2021-2026) & (k tons) Table 115. North America Oncology (Anti-cancer Drugs) Sales by Type (2027-2032) & (k tons) Table 116. North America Oncology (Anti-cancer Drugs) Sales Price by Type (2021-2026) & (US$/ton) Table 117. North America Oncology (Anti-cancer Drugs) Sales Price by Type (2027-2032) & (US$/ton) Table 118. North America Oncology (Anti-cancer Drugs) Revenue by Application (2021-2026) & (US$ Million) Table 119. North America Oncology (Anti-cancer Drugs) Revenue by Application (2027-2032) & (US$ Million) Table 120. North America Oncology (Anti-cancer Drugs) Sales by Application (2021-2026) & (k tons) Table 121. North America Oncology (Anti-cancer Drugs) Sales by Application (2027-2032) & (k tons) Table 122. North America Oncology (Anti-cancer Drugs) Sales Price by Application (2021-2026) & (US$/ton) Table 123. North America Oncology (Anti-cancer Drugs) Sales Price by Application (2027-2032) & (US$/ton) Table 124. North America Oncology (Anti-cancer Drugs) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Oncology (Anti-cancer Drugs) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 126. North America Oncology (Anti-cancer Drugs) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 127. North America Oncology (Anti-cancer Drugs) Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 128. North America Oncology (Anti-cancer Drugs) Sales by Country (2021-2026) & (k tons) Table 129. North America Oncology (Anti-cancer Drugs) Sales by Country (2027-2032) & (k tons) Table 130. North America Oncology (Anti-cancer Drugs) Sales Price by Country (2021-2026) & (US$/ton) Table 131. North America Oncology (Anti-cancer Drugs) Sales Price by Country (2027-2032) & (US$/ton) Table 132. United States Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 133. Canada Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 134. Mexico Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 135. Europe Oncology (Anti-cancer Drugs) Revenue by Type (2021-2026) & (US$ Million) Table 136. Europe Oncology (Anti-cancer Drugs) Revenue by Type (2027-2032) & (US$ Million) Table 137. Europe Oncology (Anti-cancer Drugs) Sales by Type (2021-2026) & (k tons) Table 138. Europe Oncology (Anti-cancer Drugs) Sales by Type (2027-2032) & (k tons) Table 139. Europe Oncology (Anti-cancer Drugs) Sales Price by Type (2021-2026) & (US$/ton) Table 140. Europe Oncology (Anti-cancer Drugs) Sales Price by Type (2027-2032) & (US$/ton) Table 141. Europe Oncology (Anti-cancer Drugs) Revenue by Application (2021-2026) & (US$ Million) Table 142. Europe Oncology (Anti-cancer Drugs) Revenue by Application (2027-2032) & (US$ Million) Table 143. Europe Oncology (Anti-cancer Drugs) Sales by Application (2021-2026) & (k tons) Table 144. Europe Oncology (Anti-cancer Drugs) Sales by Application (2027-2032) & (k tons) Table 145. Europe Oncology (Anti-cancer Drugs) Sales Price by Application (2021-2026) & (US$/ton) Table 146. Europe Oncology (Anti-cancer Drugs) Sales Price by Application (2027-2032) & (US$/ton) Table 147. Europe Oncology (Anti-cancer Drugs) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Europe Oncology (Anti-cancer Drugs) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. Europe Oncology (Anti-cancer Drugs) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. Europe Oncology (Anti-cancer Drugs) Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 151. Europe Oncology (Anti-cancer Drugs) Sales by Country (2021-2026) & (k tons) Table 152. Europe Oncology (Anti-cancer Drugs) Sales by Country (2027-2032) & (k tons) Table 153. Europe Oncology (Anti-cancer Drugs) Sales Price by Country (2021-2026) & (US$/ton) Table 154. Europe Oncology (Anti-cancer Drugs) Sales Price by Country (2027-2032) & (US$/ton) Table 155. Germany Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 156. France Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 157. U.K. Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 158. Italy Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 159. Russia Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 160. Spain Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 161. Netherlands Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 162. Switzerland Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 163. Sweden Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 164. Poland Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 165. China Oncology (Anti-cancer Drugs) Revenue by Type (2021-2026) & (US$ Million) Table 166. China Oncology (Anti-cancer Drugs) Revenue by Type (2027-2032) & (US$ Million) Table 167. China Oncology (Anti-cancer Drugs) Sales by Type (2021-2026) & (k tons) Table 168. China Oncology (Anti-cancer Drugs) Sales by Type (2027-2032) & (k tons) Table 169. China Oncology (Anti-cancer Drugs) Sales Price by Type (2021-2026) & (US$/ton) Table 170. China Oncology (Anti-cancer Drugs) Sales Price by Type (2027-2032) & (US$/ton) Table 171. China Oncology (Anti-cancer Drugs) Revenue by Application (2021-2026) & (US$ Million) Table 172. China Oncology (Anti-cancer Drugs) Revenue by Application (2027-2032) & (US$ Million) Table 173. China Oncology (Anti-cancer Drugs) Sales by Application (2021-2026) & (k tons) Table 174. China Oncology (Anti-cancer Drugs) Sales by Application (2027-2032) & (k tons) Table 175. China Oncology (Anti-cancer Drugs) Sales Price by Application (2021-2026) & (US$/ton) Table 176. China Oncology (Anti-cancer Drugs) Sales Price by Application (2027-2032) & (US$/ton) Table 177. Asia Oncology (Anti-cancer Drugs) Revenue by Type (2021-2026) & (US$ Million) Table 178. Asia Oncology (Anti-cancer Drugs) Revenue by Type (2027-2032) & (US$ Million) Table 179. Asia Oncology (Anti-cancer Drugs) Sales by Type (2021-2026) & (k tons) Table 180. Asia Oncology (Anti-cancer Drugs) Sales by Type (2027-2032) & (k tons) Table 181. Asia Oncology (Anti-cancer Drugs) Sales Price by Type (2021-2026) & (US$/ton) Table 182. Asia Oncology (Anti-cancer Drugs) Sales Price by Type (2027-2032) & (US$/ton) Table 183. Asia Oncology (Anti-cancer Drugs) Revenue by Application (2021-2026) & (US$ Million) Table 184. Asia Oncology (Anti-cancer Drugs) Revenue by Application (2027-2032) & (US$ Million) Table 185. Asia Oncology (Anti-cancer Drugs) Sales by Application (2021-2026) & (k tons) Table 186. Asia Oncology (Anti-cancer Drugs) Sales by Application (2027-2032) & (k tons) Table 187. Asia Oncology (Anti-cancer Drugs) Sales Price by Application (2021-2026) & (US$/ton) Table 188. Asia Oncology (Anti-cancer Drugs) Sales Price by Application (2027-2032) & (US$/ton) Table 189. Asia Oncology (Anti-cancer Drugs) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. Asia Oncology (Anti-cancer Drugs) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. Asia Oncology (Anti-cancer Drugs) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. Asia Oncology (Anti-cancer Drugs) Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 193. Asia Oncology (Anti-cancer Drugs) Sales by Country (2021-2026) & (k tons) Table 194. Asia Oncology (Anti-cancer Drugs) Sales by Country (2027-2032) & (k tons) Table 195. Asia Oncology (Anti-cancer Drugs) Sales Price by Country (2021-2026) & (US$/ton) Table 196. Asia Oncology (Anti-cancer Drugs) Sales Price by Country (2027-2032) & (US$/ton) Table 197. Japan Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 198. South Korea Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 199. India Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 200. Australia Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 201. Taiwan Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 202. Southeast Asia Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 203. SAMEA Oncology (Anti-cancer Drugs) Revenue by Type (2021-2026) & (US$ Million) Table 204. SAMEA Oncology (Anti-cancer Drugs) Revenue by Type (2027-2032) & (US$ Million) Table 205. SAMEA Oncology (Anti-cancer Drugs) Sales by Type (2021-2026) & (k tons) Table 206. SAMEA Oncology (Anti-cancer Drugs) Sales by Type (2027-2032) & (k tons) Table 207. SAMEA Oncology (Anti-cancer Drugs) Sales Price by Type (2021-2026) & (US$/ton) Table 208. SAMEA Oncology (Anti-cancer Drugs) Sales Price by Type (2027-2032) & (US$/ton) Table 209. SAMEA Oncology (Anti-cancer Drugs) Revenue by Application (2021-2026) & (US$ Million) Table 210. SAMEA Oncology (Anti-cancer Drugs) Revenue by Application (2027-2032) & (US$ Million) Table 211. SAMEA Oncology (Anti-cancer Drugs) Sales by Application (2021-2026) & (k tons) Table 212. SAMEA Oncology (Anti-cancer Drugs) Sales by Application (2027-2032) & (k tons) Table 213. SAMEA Oncology (Anti-cancer Drugs) Sales Price by Application (2021-2026) & (US$/ton) Table 214. SAMEA Oncology (Anti-cancer Drugs) Sales Price by Application (2027-2032) & (US$/ton) Table 215. SAMEA Oncology (Anti-cancer Drugs) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 216. SAMEA Oncology (Anti-cancer Drugs) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 217. SAMEA Oncology (Anti-cancer Drugs) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 218. SAMEA Oncology (Anti-cancer Drugs) Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 219. SAMEA Oncology (Anti-cancer Drugs) Sales by Country (2021-2026) & (k tons) Table 220. SAMEA Oncology (Anti-cancer Drugs) Sales by Country (2027-2032) & (k tons) Table 221. SAMEA Oncology (Anti-cancer Drugs) Sales Price by Country (2021-2026) & (US$/ton) Table 222. SAMEA Oncology (Anti-cancer Drugs) Sales Price by Country (2027-2032) & (US$/ton) Table 223. Brazil Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 224. Argentina Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 225. Chile Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 226. Colombia Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 227. Peru Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 228. Saudi Arabia Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 229. Israel Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 230. UAE Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 231. Turkey Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 232. Iran Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 233. Egypt Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Table 234. Key Raw Materials Table 235. Raw Materials Key Suppliers Table 236. Oncology (Anti-cancer Drugs) Distributors List Table 237. Oncology (Anti-cancer Drugs) Customers List Table 238. Research Programs/Design for This Report Table 239. Authors List of This Report Table 240. Secondary Sources Table 241. Primary Sources List of Figures Figure 1. Oncology (Anti-cancer Drugs) Image Figure 2. Global Oncology (Anti-cancer Drugs) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oncology (Anti-cancer Drugs) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Blood Cancer Image Figure 5. Gastrointestinal Cancer Image Figure 6. Breast Cancer Image Figure 7. Prostate Cancer Image Figure 8. Others Image Figure 9. Global Oncology (Anti-cancer Drugs) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Oncology (Anti-cancer Drugs) Market Size Share 2021 VS 2025 VS 2032 Figure 11. Immunotherapy (Biologic Therapy) Image Figure 12. Hormonal Therapy Image Figure 13. Chemotherapy Image Figure 14. Targeted Therapy Image Figure 15. Others Image Figure 16. Global Oncology (Anti-cancer Drugs) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Oncology (Anti-cancer Drugs) Revenue (2021-2032) & (US$ Million) Figure 18. Global Oncology (Anti-cancer Drugs) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Region (2021-2032) Figure 21. Global Oncology (Anti-cancer Drugs) Sales (2021-2032) & (k tons) Figure 22. Global Oncology (Anti-cancer Drugs) Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 23. Global Oncology (Anti-cancer Drugs) Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Oncology (Anti-cancer Drugs) Sales YoY (2021-2032) & (k tons) Figure 25. Europe Oncology (Anti-cancer Drugs) Sales YoY (2021-2032) & (k tons) Figure 26. China Oncology (Anti-cancer Drugs) Sales YoY (2021-2032) & (k tons) Figure 27. Asia (Excluding China) Oncology (Anti-cancer Drugs) Sales YoY (2021-2032) & (k tons) Figure 28. South America, Middle East and Africa Oncology (Anti-cancer Drugs) Sales YoY (2021-2032) & (k tons) Figure 29. Global Oncology (Anti-cancer Drugs) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Oncology (Anti-cancer Drugs) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Oncology (Anti-cancer Drugs) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Type (2021-2032) Figure 35. Global Oncology (Anti-cancer Drugs) Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 36. Global Oncology (Anti-cancer Drugs) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Oncology (Anti-cancer Drugs) Sales Market Share by Type (2021-2032) Figure 38. Global Oncology (Anti-cancer Drugs) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Application (2021-2032) Figure 41. Global Oncology (Anti-cancer Drugs) Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 42. Global Oncology (Anti-cancer Drugs) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Oncology (Anti-cancer Drugs) Sales Market Share by Application (2021-2032) Figure 44. North America Oncology (Anti-cancer Drugs) Revenue Share by Type (2021-2032) Figure 45. North America Oncology (Anti-cancer Drugs) Sales Share by Type (2021-2032) Figure 46. North America Oncology (Anti-cancer Drugs) Revenue Share by Application (2021-2032) Figure 47. North America Oncology (Anti-cancer Drugs) Sales Share by Application (2021-2032) Figure 48. North America Oncology (Anti-cancer Drugs) Revenue Share by Country (2021-2032) Figure 49. North America Oncology (Anti-cancer Drugs) Sales Share by Country (2021-2032) Figure 50. Europe Oncology (Anti-cancer Drugs) Revenue Share by Type (2021-2032) Figure 51. Europe Oncology (Anti-cancer Drugs) Sales Share by Type (2021-2032) Figure 52. Europe Oncology (Anti-cancer Drugs) Revenue Share by Application (2021-2032) Figure 53. Europe Oncology (Anti-cancer Drugs) Sales Share by Application (2021-2032) Figure 54. Europe Oncology (Anti-cancer Drugs) Revenue Share by Country (2021-2032) Figure 55. Europe Oncology (Anti-cancer Drugs) Sales Share by Country (2021-2032) Figure 56. China Oncology (Anti-cancer Drugs) Revenue Share by Type (2021-2032) Figure 57. China Oncology (Anti-cancer Drugs) Sales Share by Type (2021-2032) Figure 58. China Oncology (Anti-cancer Drugs) Revenue Share by Application (2021-2032) Figure 59. China Oncology (Anti-cancer Drugs) Sales Share by Application (2021-2032) Figure 60. Asia Oncology (Anti-cancer Drugs) Revenue Share by Type (2021-2032) Figure 61. Asia Oncology (Anti-cancer Drugs) Sales Share by Type (2021-2032) Figure 62. Asia Oncology (Anti-cancer Drugs) Revenue Share by Application (2021-2032) Figure 63. Asia Oncology (Anti-cancer Drugs) Sales Share by Application (2021-2032) Figure 64. Asia Oncology (Anti-cancer Drugs) Revenue Share by Country (2021-2032) Figure 65. Asia Oncology (Anti-cancer Drugs) Sales Share by Country (2021-2032) Figure 66. SAMEA Oncology (Anti-cancer Drugs) Revenue Share by Type (2021-2032) Figure 67. SAMEA Oncology (Anti-cancer Drugs) Sales Share by Type (2021-2032) Figure 68. SAMEA Oncology (Anti-cancer Drugs) Revenue Share by Application (2021-2032) Figure 69. SAMEA Oncology (Anti-cancer Drugs) Sales Share by Application (2021-2032) Figure 70. SAMEA Oncology (Anti-cancer Drugs) Revenue Share by Country (2021-2032) Figure 71. SAMEA Oncology (Anti-cancer Drugs) Sales Share by Country (2021-2032) Figure 72. Oncology (Anti-cancer Drugs) Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Oncology (Anti-cancer Drugs) Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Cancer
  • Gastrointestinal Cancer
  • Breast Cancer
  • Prostate Cancer
  • Others
Applications
  • Immunotherapy (Biologic Therapy)
  • Hormonal Therapy
  • Chemotherapy
  • Targeted Therapy
  • Others
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck
  • Roche
  • Eli lilly
  • Pfizer
  • GlaxoSmithKline
  • Amgen
  • Celgene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Oncology (Anti-cancer Drugs) Market by Type
  3. 1.2.1 Global Oncology (Anti-cancer Drugs) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Blood Cancer
  5. 1.2.3 Gastrointestinal Cancer
  6. 1.2.4 Breast Cancer
  7. 1.2.5 Prostate Cancer
  8. 1.2.6 Others
  9. 1.3 Oncology (Anti-cancer Drugs) Market by Application
  10. 1.3.1 Global Oncology (Anti-cancer Drugs) Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Immunotherapy (Biologic Therapy)
  12. 1.3.3 Hormonal Therapy
  13. 1.3.4 Chemotherapy
  14. 1.3.5 Targeted Therapy
  15. 1.3.6 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Oncology (Anti-cancer Drugs) Market Dynamics
  1. 2.1 Oncology (Anti-cancer Drugs) Industry Trends
  2. 2.2 Oncology (Anti-cancer Drugs) Industry Drivers
  3. 2.3 Oncology (Anti-cancer Drugs) Industry Opportunities and Challenges
  4. 2.4 Oncology (Anti-cancer Drugs) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Oncology (Anti-cancer Drugs) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Oncology (Anti-cancer Drugs) Revenue by Region
  3. 3.2.1 Global Oncology (Anti-cancer Drugs) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Oncology (Anti-cancer Drugs) Revenue by Region (2021-2026)
  5. 3.2.3 Global Oncology (Anti-cancer Drugs) Revenue by Region (2027-2032)
  6. 3.2.4 Global Oncology (Anti-cancer Drugs) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Oncology (Anti-cancer Drugs) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Oncology (Anti-cancer Drugs) Sales by Region
  9. 3.4.1 Global Oncology (Anti-cancer Drugs) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Oncology (Anti-cancer Drugs) Sales by Region (2021-2026)
  11. 3.4.3 Global Oncology (Anti-cancer Drugs) Sales by Region (2027-2032)
  12. 3.4.4 Global Oncology (Anti-cancer Drugs) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Oncology (Anti-cancer Drugs) Revenue by Manufacturers
  2. 4.1.1 Global Oncology (Anti-cancer Drugs) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Oncology (Anti-cancer Drugs) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Oncology (Anti-cancer Drugs) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Oncology (Anti-cancer Drugs) Sales by Manufacturers
  6. 4.2.1 Global Oncology (Anti-cancer Drugs) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Oncology (Anti-cancer Drugs) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Oncology (Anti-cancer Drugs) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Oncology (Anti-cancer Drugs) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Oncology (Anti-cancer Drugs) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Oncology (Anti-cancer Drugs) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Oncology (Anti-cancer Drugs) Manufacturers, Product Type & Application
  13. 4.7 Global Oncology (Anti-cancer Drugs) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Oncology (Anti-cancer Drugs) Market CR5 and HHI
  16. 4.8.2 2025 Oncology (Anti-cancer Drugs) Tier 1, Tier 2, and Tier 3
5 Oncology (Anti-cancer Drugs) Market by Type
  1. 5.1 Global Oncology (Anti-cancer Drugs) Revenue by Type
  2. 5.1.1 Global Oncology (Anti-cancer Drugs) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Oncology (Anti-cancer Drugs) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Oncology (Anti-cancer Drugs) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Oncology (Anti-cancer Drugs) Sales by Type
  6. 5.2.1 Global Oncology (Anti-cancer Drugs) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Oncology (Anti-cancer Drugs) Sales by Type (2021-2032) & (k tons)
  8. 5.2.3 Global Oncology (Anti-cancer Drugs) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Oncology (Anti-cancer Drugs) Price by Type
6 Oncology (Anti-cancer Drugs) Market by Application
  1. 6.1 Global Oncology (Anti-cancer Drugs) Revenue by Application
  2. 6.1.1 Global Oncology (Anti-cancer Drugs) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Oncology (Anti-cancer Drugs) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Oncology (Anti-cancer Drugs) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Oncology (Anti-cancer Drugs) Sales by Application
  6. 6.2.1 Global Oncology (Anti-cancer Drugs) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Oncology (Anti-cancer Drugs) Sales by Application (2021-2032) & (k tons)
  8. 6.2.3 Global Oncology (Anti-cancer Drugs) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Oncology (Anti-cancer Drugs) Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Oncology (Anti-cancer Drugs) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Oncology (Anti-cancer Drugs) Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Johnson & Johnson
  8. 7.2.1 Johnson & Johnson Company Information
  9. 7.2.2 Johnson & Johnson Business Overview
  10. 7.2.3 Johnson & Johnson Oncology (Anti-cancer Drugs) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Johnson & Johnson Oncology (Anti-cancer Drugs) Product Portfolio
  12. 7.2.5 Johnson & Johnson Recent Developments
  13. 7.3 Novartis
  14. 7.3.1 Novartis Company Information
  15. 7.3.2 Novartis Business Overview
  16. 7.3.3 Novartis Oncology (Anti-cancer Drugs) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Novartis Oncology (Anti-cancer Drugs) Product Portfolio
  18. 7.3.5 Novartis Recent Developments
  19. 7.4 Merck
  20. 7.4.1 Merck Company Information
  21. 7.4.2 Merck Business Overview
  22. 7.4.3 Merck Oncology (Anti-cancer Drugs) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Merck Oncology (Anti-cancer Drugs) Product Portfolio
  24. 7.4.5 Merck Recent Developments
  25. 7.5 Roche
  26. 7.5.1 Roche Company Information
  27. 7.5.2 Roche Business Overview
  28. 7.5.3 Roche Oncology (Anti-cancer Drugs) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Roche Oncology (Anti-cancer Drugs) Product Portfolio
  30. 7.5.5 Roche Recent Developments
  31. 7.6 Eli lilly
  32. 7.6.1 Eli lilly Company Information
  33. 7.6.2 Eli lilly Business Overview
  34. 7.6.3 Eli lilly Oncology (Anti-cancer Drugs) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Eli lilly Oncology (Anti-cancer Drugs) Product Portfolio
  36. 7.6.5 Eli lilly Recent Developments
  37. 7.7 Pfizer
  38. 7.7.1 Pfizer Company Information
  39. 7.7.2 Pfizer Business Overview
  40. 7.7.3 Pfizer Oncology (Anti-cancer Drugs) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer Oncology (Anti-cancer Drugs) Product Portfolio
  42. 7.7.5 Pfizer Recent Developments
  43. 7.8 GlaxoSmithKline
  44. 7.8.1 GlaxoSmithKline Company Information
  45. 7.8.2 GlaxoSmithKline Business Overview
  46. 7.8.3 GlaxoSmithKline Oncology (Anti-cancer Drugs) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 GlaxoSmithKline Oncology (Anti-cancer Drugs) Product Portfolio
  48. 7.8.5 GlaxoSmithKline Recent Developments
  49. 7.9 Amgen
  50. 7.9.1 Amgen Company Information
  51. 7.9.2 Amgen Business Overview
  52. 7.9.3 Amgen Oncology (Anti-cancer Drugs) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Amgen Oncology (Anti-cancer Drugs) Product Portfolio
  54. 7.9.5 Amgen Recent Developments
  55. 7.10 Celgene
  56. 7.10.1 Celgene Company Information
  57. 7.10.2 Celgene Business Overview
  58. 7.10.3 Celgene Oncology (Anti-cancer Drugs) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Celgene Oncology (Anti-cancer Drugs) Product Portfolio
  60. 7.10.5 Celgene Recent Developments
8 North America
  1. 8.1 North America Oncology (Anti-cancer Drugs) Market Size by Type
  2. 8.1.1 North America Oncology (Anti-cancer Drugs) Revenue by Type (2021-2032)
  3. 8.1.2 North America Oncology (Anti-cancer Drugs) Sales by Type (2021-2032)
  4. 8.1.3 North America Oncology (Anti-cancer Drugs) Price by Type (2021-2032)
  5. 8.2 North America Oncology (Anti-cancer Drugs) Market Size by Application
  6. 8.2.1 North America Oncology (Anti-cancer Drugs) Revenue by Application (2021-2032)
  7. 8.2.2 North America Oncology (Anti-cancer Drugs) Sales by Application (2021-2032)
  8. 8.2.3 North America Oncology (Anti-cancer Drugs) Price by Application (2021-2032)
  9. 8.3 North America Oncology (Anti-cancer Drugs) Market Size by Country
  10. 8.3.1 North America Oncology (Anti-cancer Drugs) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Oncology (Anti-cancer Drugs) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Oncology (Anti-cancer Drugs) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Oncology (Anti-cancer Drugs) Market Size by Type
  2. 9.1.1 Europe Oncology (Anti-cancer Drugs) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Oncology (Anti-cancer Drugs) Sales by Type (2021-2032)
  4. 9.1.3 Europe Oncology (Anti-cancer Drugs) Price by Type (2021-2032)
  5. 9.2 Europe Oncology (Anti-cancer Drugs) Market Size by Application
  6. 9.2.1 Europe Oncology (Anti-cancer Drugs) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Oncology (Anti-cancer Drugs) Sales by Application (2021-2032)
  8. 9.2.3 Europe Oncology (Anti-cancer Drugs) Price by Application (2021-2032)
  9. 9.3 Europe Oncology (Anti-cancer Drugs) Market Size by Country
  10. 9.3.1 Europe Oncology (Anti-cancer Drugs) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Oncology (Anti-cancer Drugs) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Oncology (Anti-cancer Drugs) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Oncology (Anti-cancer Drugs) Market Size by Type
  2. 10.1.1 China Oncology (Anti-cancer Drugs) Revenue by Type (2021-2032)
  3. 10.1.2 China Oncology (Anti-cancer Drugs) Sales by Type (2021-2032)
  4. 10.1.3 China Oncology (Anti-cancer Drugs) Price by Type (2021-2032)
  5. 10.2 China Oncology (Anti-cancer Drugs) Market Size by Application
  6. 10.2.1 China Oncology (Anti-cancer Drugs) Revenue by Application (2021-2032)
  7. 10.2.2 China Oncology (Anti-cancer Drugs) Sales by Application (2021-2032)
  8. 10.2.3 China Oncology (Anti-cancer Drugs) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Oncology (Anti-cancer Drugs) Market Size by Type
  2. 11.1.1 Asia Oncology (Anti-cancer Drugs) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Oncology (Anti-cancer Drugs) Sales by Type (2021-2032)
  4. 11.1.3 Asia Oncology (Anti-cancer Drugs) Price by Type (2021-2032)
  5. 11.2 Asia Oncology (Anti-cancer Drugs) Market Size by Application
  6. 11.2.1 Asia Oncology (Anti-cancer Drugs) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Oncology (Anti-cancer Drugs) Sales by Application (2021-2032)
  8. 11.2.3 Asia Oncology (Anti-cancer Drugs) Price by Application (2021-2032)
  9. 11.3 Asia Oncology (Anti-cancer Drugs) Market Size by Country
  10. 11.3.1 Asia Oncology (Anti-cancer Drugs) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Oncology (Anti-cancer Drugs) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Oncology (Anti-cancer Drugs) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Oncology (Anti-cancer Drugs) Market Size by Type
  2. 12.1.1 SAMEA Oncology (Anti-cancer Drugs) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Oncology (Anti-cancer Drugs) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Oncology (Anti-cancer Drugs) Price by Type (2021-2032)
  5. 12.2 SAMEA Oncology (Anti-cancer Drugs) Market Size by Application
  6. 12.2.1 SAMEA Oncology (Anti-cancer Drugs) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Oncology (Anti-cancer Drugs) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Oncology (Anti-cancer Drugs) Price by Application (2021-2032)
  9. 12.3 SAMEA Oncology (Anti-cancer Drugs) Market Size by Country
  10. 12.3.1 SAMEA Oncology (Anti-cancer Drugs) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Oncology (Anti-cancer Drugs) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Oncology (Anti-cancer Drugs) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Oncology (Anti-cancer Drugs) Value Chain Analysis
  2. 13.1.1 Oncology (Anti-cancer Drugs) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Oncology (Anti-cancer Drugs) Production Mode & Process
  6. 13.2 Oncology (Anti-cancer Drugs) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Oncology (Anti-cancer Drugs) Distributors
  9. 13.2.3 Oncology (Anti-cancer Drugs) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst